The DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index; none of the 7 sources its claims cite is checked for support yet.
FIH-1: a novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity
Open accessAbstract
Hypoxia-inducible factor 1 (HIF-1) is a master regulator of oxygen homeostasis that controls angiogenesis, erythropoiesis, and glycolysis via transcriptional activation of target genes under hypoxic conditions. O 2 -dependent binding of the von Hippel-Lindau (VHL) tumor suppressor protein targets the HIF-1α subunit for ubiquitination and proteasomal degradation. The activity of the HIF-1α transactivation domains is also O 2 regulated by a previously undefined mechanism. Here, we report the identification of factor inhibiting HIF-1 (FIH-1), a protein that binds to HIF-1α and inhibits its transactivation function. In addition, we demonstrate that FIH-1 binds to VHL and that VHL also functions as a transcriptional corepressor that inhibits HIF-1α transactivation function by recruiting histone deacetylases. Involvement of VHL in association with FIH-1 provides a unifying mechanism for the modulation of HIF-1α protein stabilization and transcriptional activation in response to changes in cellular O 2 concentration.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
The paper identifies FIH-1, a 349-amino-acid protein that binds HIF-1α and VHL and represses HIF-1 transcriptional activity. It proposes that VHL and FIH-1 act as corepressors by recruiting histone deacetylases, unifying O₂-dependent control of HIF-1α stability and transactivation.
Key findings
- A yeast two-hybrid screen of 2 × 10⁶ transformants identified FIH-1 from a 2.98-kb human brain cDNA encoding a 349-amino-acid protein; the FIH1 gene maps to chromosome 10q24 and consists of eight exons and seven introns spanning 14 kb.
- FIH-1 binds HIF-1α residues 531–826, with optimal binding requiring TAD-C; residues 757–826 are sufficient, whereas TAD-N (531–575) and TAD-C alone (786–826) did not bind.
- FIH-1 inhibits HIF-1α transactivation in 293 and Hep3B reporter assays at 1% O₂; antisense FIH-1 increases reporter expression, and FIH-1 inhibits GalA (HIF-1α 531–826) under both 20% and 1% O₂.
- FIH-1 binds VHL at a distinct site (VHL residues 1–155 sufficient for FIH-1 binding; 1–213 required for efficient HIF-1α binding), and VHL plus FIH-1 cooperatively repress GalL (HIF-1α 531–575); VHL binds HDAC-1, HDAC-2, and HDAC-3 and recruits HDACs to HIF-1α.
Methods
- Yeast two-hybrid assay using GAL4 DBD–HIF-1α(576–826) bait and a human brain cDNA prey library; 2 × 10⁶ transformants screened for histidine auxotrophy and α-galactosidase expression.
- In vitro GST pull-down assays with ³⁵S-labeled HIF-1α, FIH-1, VHL, and HDAC proteins; some GST-HIF-1α fusions were preincubated with reticulocyte lysate to induce proline hydroxylation.
- Transient transfection of HEK293 and Hep3B cells with p2.1 or pG5ElbLuc reporters and GAL4–HIF-1α fusion constructs, exposed to 20% or 1% O₂; immunoprecipitation and immunoblot assays for protein interactions.
Limitations
- Stated: coimmunoprecipitation of FIH-1 and HIF-1α was detected in cells overexpressing these proteins, so no conclusion can be drawn as to whether the interaction is regulated by cellular O₂ concentration; VHL expression may have been limiting, and no interaction of VHL with FIH-1 or HIF-1α could be demonstrated under those conditions.
- Stated: whether O₂-dependent interaction of HIF-1α and VHL is required for recruitment of FIH-1 remains unanswered; an alternative but not mutually exclusive hypothesis is that FIH-1 and VHL recruit distinct HDAC complexes.
- Evident: many interaction and repression conclusions rely on overexpression and in vitro binding assays; FIH-1’s weaker HDAC binding and the possibilities that it interacts with HDAC-4–7, another corepressor, or possesses intrinsic HDAC activity are speculative and not demonstrated.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
14 Own result · 5 Own interpretation · 4 Not checked yet · 1 Own method
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Interaction of VHL and FIH-1 with histone deacetylases.”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Immunoprecipitation assay
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Functional interaction of FIH-1 and VHL to repress HIF-1␣ transactivation domain function.”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Immunoprecipitation assay
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Effect of FIH-1 on HIF-1-mediated reporter gene transcription.”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Immunoprecipitation assay
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Interaction of FIH-1, HIF-1␣, and VHL in vitro.”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Immunoprecipitation assay
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Identification of FIH-1 by yeast two-hybrid screen.”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Immunoprecipitation assay
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The physical interaction of bait and prey proteins within yeast cells functionally reconstitutes an active GAL4 transcription factor, resulting in expression of genes containing upstream GAL4-binding sites that mediate histidine auxotrophy and α-gal expression.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Interaction of FIH-1 and HIF-1␣ in human cells.”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Immunoprecipitation assay
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Localization of HIF-1␣ residues interacting with FIH-1.”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Immunoprecipitation assay
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“binding of VHL to the intact HIF-1␣ regulatory domain (residues 531-826) does not require preincubation of HIF-1␣ with cellular lysate (as a source of putative prolyl hydroxylase activity; Fig. 4D)”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“TBLASTN searches revealed similarity of FIH-1 to the rat PASS1 protein (GenBank accession no.AF168362.1),proteins encoded by human ESTs FLJ13798 (AK023860.1)and FLJ20656 (AK000663.1),as well as to open reading frames in Caenorhabditis briggsae (AC084551.1)and Drosophila melanogaster (AE003469.2,AE003537.2) genomic DNA, thus defining a family of related proteins that has been conserved through inve”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Identification of FIH-1 in a screen for HIF-1␣-interacting proteins
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Thus, FIH-1 loss-of-function may contribute to increased HIF-1-mediated transactivation of downstream target genes such as VEGF in gliomas and other human cancers (Semenza 2000; Zagzag et al. 2000).”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Discussion
What the sources say
- Not checked yetcites Semenza 2000
- Not checked yetcites Zagzag et al. 2000
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- It may state two separate claims as one. 4
- Probably not a substantial claim. 3
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Nucleotide sequence analysis revealed that the prey vector contained a 2.98-kb human cDNA encoding a 349-amino-acid protein that was subsequently designated FIH-1 (GenBank accession no.AF395830).”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Identification of FIH-1 in a screen for HIF-1␣-interacting proteins
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Analysis of genomic DNA sequences deposited in Gen-Bank revealed that the FIH1 gene is present in contig NT 008635, which is mapped to human chromosome 10q24, and consists of eight exons and seven introns that span 14 kb of DNA.”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Identification of FIH-1 in a screen for HIF-1␣-interacting proteins
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither FIH-1 nor VHL alone inhibited GalL-mediated transactivation, whereas the combination of FIH-1 and VHL resulted in significant transcriptional repression.”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Inhibition of HIF-1␣ transactivation domain function by VHL and FIH-1 in human cells
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“EST data indicate that FIH-1 is expressed in multiple cell types derived from adrenal, bladder, brain (adult and fetal), breast, colon, embryo, foreskin, germ cell, heart, kidney, lung, lymph, marrow, muscle, nerve, ovary, parathyroid, prostate, skin, testis, tonsil, and uterus.”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Identification of FIH-1 in a screen for HIF-1␣-interacting proteins
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Negative regulation of HIF-1␣ protein stability and transcriptional activity under nonhypoxic conditions mediated by VHL and FIH-1.”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Immunoprecipitation assay
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: Elongins B and C and cullin 2 are required for E3 ubiquitin-protein ligase activity, whereas HDACs repress transactivation.
In the paper
“Residues 576-785 comprise an inhibitory domain the deletion of which increases transactivation domain function especially under nonhypoxic conditions (Jiang et al. 1997).”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Abstract
What the sources say
- Not checked yetcites Jiang et al. 1997
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
The paper relies on this without support.
HIF-1 activity is induced by hypoxia in all cell types.
“Because HIF-1 activity is induced by hypoxia in all cell types, the interaction of HIF-1 with other proteins is likely to play a major role in determining its biological activity.”
The paper relies on this without support.
HIF-1α contains basic helix-loop-helix (bHLH) and PAS domains required for dimerization and DNA binding, a proline/serine/threonine-rich protein stabilization domain (PSTD), two transactivation domains (TAD-N and TAD-C), and an inhibitory domain (ID) that negatively regulates transactivation domain function under nonhypoxic conditions.
“HIF-1␣ contains basic helix-loop-helix (bHLH) and PAS domains that are required for dimerization and DNA binding, a proline/serine/threonine-rich protein stabilization domain (PSTD), two transactivation domains (TAD-N and TAD-C), and an inhibitory domain (ID) that negatively regulates transactivation domain function under nonhypoxic conditions.”
The paper relies on this without support.
Elongins B and C and cullin 2 are required for E3 ubiquitin-protein ligase activity, whereas HDACs repress transactivation.
“Elongins B and C and cullin 2 are required for E3 ubiquitin-protein ligase activity, whereas HDACs repress transactivation.”
The paper relies on this without support.
The physical interaction of bait and prey proteins within yeast cells functionally reconstitutes an active GAL4 transcription factor, resulting in expression of genes containing upstream GAL4-binding sites that mediate histidine auxotrophy and α-gal expression.
“The physical interaction of the bait and prey proteins within yeast cells functionally reconstitutes an active GAL4 transcription factor, resulting in the expression of genes that contain upstream GAL4-binding sites and mediate histidine auxotrophy (his + ) and ␣-gal expression.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“although it remains capable of binding the CAD under these conditions (Mahon et al. 2001).”
From FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor (2002) · cites this paper as Mahon et al. 2001
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“HIF transcriptional activity is also regulated by a second oxygen-sensitive hydroxylation event mediated by factor inhibiting HIF-1 (FIH-1) (Mahon et al., 2001;Lando et al., 2002).”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Mahon et al., 2001
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This mechanism attenuates HIF transcriptional activity during early reoxygenation, acting as a buffer that limits the excessive metabolic activation and oxidative stress during the transition from hypoxia to normoxia”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [52]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“FIH-1 functions at lower oxygen tensions than PHDs and hydroxylates a single asparagine residue within the C-terminal transactivation domain of HIF-1α, consequently limiting engagement of transcriptional co-activator complexes [52,53]”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [52]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Although the two modes of regulation can be apparently uncoupled from each other through the construction of chimeras containing either the ODD or the CAD, the machinery regulating the two appears to be linked (Mahon et al. 2001).”
From FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor (2002) · cites this paper as Mahon et al. 2001
The cited source says what the claim attributes to it.
In the citing paper
“In vitro binding studies suggest that FIH-1 and pVHL interact and may be part of a larger complex that represses HIF by multiple mechanisms under normoxic conditions (Mahon et al. 2001)”
From FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor (2002) · cites this paper as Mahon et al. 2001
In the citing paper
“Hif-1α is also hydroxylated in an oxygen-dependent reaction on a highly conserved asparagine residue by FIH-1 (Factor inhibiting HIF-1), which blocks the ability of Hif-1α to recruit transcriptional coactivators such as p300/CBP, in turn limiting transcriptional activation by Hif-1α under non-hypoxic conditions [45, 46].”
From Hypoxia and hypoxia-inducible factors as regulators of T cell development, differentiation, and function (2013) · cites this paper as [45]
Citations
Cites
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Self-citationA novel genetic system to detect protein–protein interactions
Fields, S., & Song, O.-K. (1989) · Nature · doi:10.1038/340245a0 · Cited by 6,152
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502
Hoffman, C. S., & Winston, F. (1987) · Gene · doi:10.1016/0378-1119(87)90131-4 · Cited by 2,492
Cellular and developmental control of O 2 homeostasis by hypoxia-inducible factor 1α
Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y., et al. (1998) · Genes & Development · doi:10.1101/gad.12.2.149 · Cited by 2,476
Self-citationHuang, L. E., Gu, J., Schau, M., & Bunn, H. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.7987 · Cited by 2,113
Purification and Characterization of Hypoxia-inducible Factor 1
Wang, G. L., & Semenza, G. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.3.1230 · Cited by 2,094
Self-citation
Cited by
Sorted by citations
Items 501–600 of 1,002
Understanding the Therapeutic Potential of Ascorbic Acid in the Battle to Overcome Cancer
Reang, J., Sharma, P. C., Thakur, V. K., & Majeed, J. (2021) · Biomolecules · doi:10.3390/biom11081130 · Cited by 73
Zhu, D., Wang, Y., Thomas, M., McLaughlin, K., Oguljahan, B., Henderson, J., Yang, Q., Chen, Y. E., & Liu, D. (2021) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2021.08.010 · Cited by 73
Interplay of Hypoxia and A2B Adenosine Receptors in Tissue Protection
Koeppen, M., Eckle, T. D. L. G., & Eltzschig, H. K. (2011) · Advances in pharmacology · doi:10.1016/b978-0-12-385526-8.00006-0 · Cited by 73
Superoxide and derived reactive oxygen species in the regulation of hypoxia-inducible factors
Görlach, A., & Kietzmann, T. (2007) · Methods in Enzymology · doi:10.1016/s0076-6879(07)35022-2 · Cited by 73
ATF4 promotes bone angiogenesis by increasing vegf expression and release in the bone environment
Zhu, K., Jiao, H., Li, S., Cao, H., Galson, D. L., Zhao, Z., Zhao, X., Lai, Y., Fan, J., Im, H., et al. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1958 · Cited by 73
The role of von Hippel-Lindau tumor suppressor protein and hypoxia in renal clear cell carcinoma
Sufan, R. I., Jewett, M. A. S., & Ohh, M. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00424.2003 · Cited by 75
Yang, M. H., Ge, W., Chowdhury, R., Claridge, T. D. W., Kramer, H., Schmierer, B., McDonough, M. A., Gong, L., Kessler, B. M., Ratcliffe, P. J., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.193540 · Cited by 73
Beischlag, T. V., Taylor, R. T., Rose, D. W., Yoon, D. Y., Chen, Y., Lee, W., Rosenfeld, M. G., & Hankinson, O. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410456200 · Cited by 73
Hypoxia signalling manipulation for bone regeneration
Drager, J., Harvey, E. J., & Barralet, J. E. (2015) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2015.4 · Cited by 73
Imidazole Ring-Opened DNA Purines and Their Biological Significance
Tudek, B. (2003) · BMB Reports · doi:10.5483/bmbrep.2003.36.1.012 · Cited by 75
Pseudohypoxic HIF pathway activation dysregulates collagen structure-function in human lung fibrosis
Brereton, C. J., Yao, L., Davies, E. R., Zhou, Y., Vukmirovic, M., Bell, J. A., Wang, S., Ridley, R. A., Dean, L. S. N., Andriotis, O. G., et al. (2022) · eLife · doi:10.7554/elife.69348 · Cited by 78
The von Hippel–Lindau tumour suppressor: a multi-faceted inhibitor of tumourigenesis
Barry, R. E., & Krek, W. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.07.008 · Cited by 77
Ubiquitin Pathway in VHL Cancer Syndrome
Ohh, M. (2006) · Neoplasia · doi:10.1593/neo.06442 · Cited by 72
Hypoxia regulates the hematopoietic stem cell niche
Morikawa, T., & Takubo, K. (2015) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-015-1743-z · Cited by 77
(2019) · Advances in Cancer Research · doi:10.1016/bs.acr.2018.11.001 · Cited by 71
Self-citationRoles of Brahma and Brahma/SWI2-Related Gene 1 in Hypoxic Induction of the Erythropoietin Gene
Wang, F., Zhang, R., Beischlag, T. V., Muchardt, C., Yaniv, M., & Hankinson, O. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409002200 · Cited by 72
Ascorbate Depletion: A Critical Step in Nickel Carcinogenesis?
Salnikow, K., & Kasprzak, K. S. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.7605 · Cited by 72
From Vessel Sprouting to Normalization
Coulon, C., Γεωργιάδου, Μ., Roncal, C., Bock, K. D., Langenberg, T., & Carmeliet, P. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.214106 · Cited by 72
del Balzo, U., Signore, P. E., Walkinshaw, G., Seeley, T. W., Brenner, M. C., Wang, Q., Guo, G., Arend, M., Flippin, L. A., Chow, F. A., et al. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.265181 · Cited by 71
How oxygenation shapes immune responses: emerging roles for physioxia and pathological hypoxia
Mirchandani, A. S., Sánchez-García, M. A., & Walmsley, S. R. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-024-01087-5 · Cited by 77
HIF-1 and HIF-2 in cancer: structure, regulation, and therapeutic prospects
Shi, Y., & Gilkes, D. M. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05537-0 · Cited by 81
Barth, S., Edlich, F., Berchner‐Pfannschmidt, U., Gneuss, S., Jahreis, G., Hasgall, P. A., Fandrey, J., Wenger, R. H., & Camenisch, G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.032631 · Cited by 70
Fu, J., & Taubman, M. B. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.078600 · Cited by 70
PHD2: from hypoxia regulation to disease progression
Wielockx, B., & Meneses, A. (2016) · Hypoxia · doi:10.2147/hp.s53576 · Cited by 72
Hypoxia as a Modulator of Inflammation and Immune Response in Cancer
Castillo‐Rodríguez, R. A., Trejo‐Solís, C., Cabrera‐Cano, A., Gómez‐Manzo, S., & Dávila‐Borja, V. M. (2022) · Cancers · doi:10.3390/cancers14092291 · Cited by 70
Multi-scale signaling and tumor evolution in high-grade gliomas
Liu, J., Cao, S., Imbach, K. J., Gritsenko, M. A., Lih, T. M., Kyle, J. E., Yaron-Barir, T. M., Binder, Z. A., Li, Y., Strunilin, I., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.06.004 · Cited by 71
Baek, J. H., Liu, Y. V., McDonald, K. R., Wesley, J. B., Zhang, H., & Semenza, G. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705627200 · Cited by 71
Self-citationMorris, M. R., Maina, E. N., Morgan, N. V., Gentle, D., Astuti, D., Moch, H., Kishida, T., Yao, M., Schraml, P., Richards, F. M., et al. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.011767 · Cited by 71
Reactive oxygen species attenuate nitric-oxide-mediated hypoxia-inducible factor-1α stabilization
Köhl, R., Zhou, J., & Brüne, B. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.12.012 · Cited by 71
Leu‐574 of human HIF‐1α is a molecular determinant of prolyl hydroxylation
Kageyama, Y., Koshiji, M., To, K. K. W., Tian, Y., Ratcliffe, P. J., & Huang, E. L. (2004) · The FASEB Journal · doi:10.1096/fj.03-1233fje · Cited by 70
Targeting hypoxia in tumor: a new promising therapeutic strategy
Bosco, M. C., D’Orazi, G., & Bufalo, D. D. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1517-0 · Cited by 70
Koh, M. Y., Spivak-Kroizman, T. R., & Powis, G. (2009) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-540-78281-0_3 · Cited by 70
Waalen, J., von Löhneysen, K., Lee, P. L., Xu, X., & Friedman, J. S. (2011) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2011.01631.x · Cited by 68
Influence of low oxygen tensions on macrophage polarization
Escribese, M. M., Casas, M., & Corbí, A. L. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.07.002 · Cited by 69
Natural Product-Derived Small Molecule Activators of Hypoxia-Inducible Factor-1 (HIF-1)
Nagle, D. G., & Zhou, Y. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206777698783 · Cited by 68
Kawabe, S., & Yokoyama, Y. (2011) · Marine Biotechnology · doi:10.1007/s10126-011-9394-3 · Cited by 72
Oxygen regulation of TET enzymes
Matulevičiūtė, R., Cunha, P. P., Johnson, R. S., & Foskolou, I. P. (2021) · FEBS Journal · doi:10.1111/febs.15695 · Cited by 69
Ruas, J. L., Berchner‐Pfannschmidt, U., Malik, S., Gradin, K., Fandrey, J., Roeder, R. G., Pereira, T., & Poellinger, L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.021824 · Cited by 68
Seo, H., Kim, E., Na, H., & Lee, M. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.11.044 · Cited by 71
Targeting the molecular basis for tumour hypoxia
Carroll, V. A., & Ashcroft, M. A. (2005) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399405009117 · Cited by 75
Global microRNA depletion suppresses tumor angiogenesisPreprint
Chen, S., Xue, Y., Wu, X., Cong, L., Bhutkar, A. J., Bell, E. L., Zhang, F., Langer, R., & Sharp, P. A. (2014) · Genes & Development · doi:10.1101/gad.239681.114 · Cited by 69
Nano-targeting vascular remodeling in cancer: Recent developments and future directions
Giordo, R., Wehbe, Z., Paliogiannis, P., Eid, A. H., Mangoni, A. A., & Pintus, G. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.03.001 · Cited by 67
SEPT9_v1 Up-regulates Hypoxia-inducible Factor 1 by Preventing Its RACK1-mediated Degradation
Amir, S., Wang, R., Simons, J. W., & Mabjeesh, N. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808348200 · Cited by 70
Effect of chemical stabilizers of hypoxia-inducible factors on early lung development
Groenman, F. A., Rutter, M., Wang, J., Caniggia, I., Tibboel, D., & Post, M. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00486.2006 · Cited by 66
Ma, Y., Freitag, P., Zhou, J., Brüne, B., Frede, S., & Fandrey, J. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00115.2004 · Cited by 68
Protein oxidation: role in signalling and detection by mass spectrometry
Spickett, C. M., & Pitt, A. R. (2012) · Amino Acids · doi:10.1007/s00726-010-0585-4 · Cited by 65
Stiehl, D. P., Fath, D. M., Liang, D., Jiang, Y., & Sang, N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3985 · Cited by 66
Regulation of hypoxia-inducible gene expression after HIF activation
Suzuki, N., Gradin, K., Poellinger, L., & Yamamoto, M. P. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.03.013 · Cited by 68
Baek, J. H., Liu, Y. V., McDonald, K. R., Wesley, J. B., Hubbi, M. E., Byun, H., & Semenza, G. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703504200 · Cited by 66
Self-citationJAK2 unmutated erythrocytosis: current diagnostic approach and therapeutic views
Gangat, N., Szuber, N., Pardanani, A. D., & Tefferi, A. (2021) · Leukemia · doi:10.1038/s41375-021-01290-6 · Cited by 66
Ellis, L., & Пили, Р. (2010) · Pharmaceuticals · doi:10.3390/ph3082441 · Cited by 65
Hypoxia-Inducible Factor 1 Regulation through Cross Talk between mTOR and MT1-MMP
Sakamoto, T., Weng, J. S., Hara, T., Yoshino, S., Kozuka‐Hata, H., Oyama, M., & Seiki, M. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01169-13 · Cited by 64
Melatonin and the von Hippel–Lindau/HIF-1 oxygen sensing mechanism: A review
Vriend, J. P., & Reiter, R. J. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.02.004 · Cited by 68
Therapeutic targeting of the HIF oxygen-sensing pathway: Lessons learned from clinical studies
Haase, V. H. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.05.004 · Cited by 65
Harnessing the Response to Tissue Hypoxia HIF-1α and Therapeutic Angiogenesis
Vincent, K. A. (2002) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(02)00186-x · Cited by 64
Datta, K., Li, J., Bhattacharya, R., Gasparian, L., Wang, E., & Mukhopadhyay, D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2706 · Cited by 64
Xu, J., Liu, X., Zhao, F., Zhang, Y., & Wang, Z. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01654-2 · Cited by 63
Disease Mechanisms of Perioperative Organ Injury
Conrad, C., & Eltzschig, H. K. (2020) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000005191 · Cited by 63
Oxygen sensing and adaptability won the 2019 Nobel Prize in Physiology or medicine
Zhang, Q. H., Yan, Q., Yang, H., & Wei, W. (2019) · Genes & Diseases · doi:10.1016/j.gendis.2019.10.006 · Cited by 65
Amir, S., Wang, R., Matzkin, H., Simons, J. W., & Mabjeesh, N. J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2738 · Cited by 67
Overactivated NRF2 induces pseudohypoxia in hepatocellular carcinoma by stabilizing HIF-1α
Zheng, J., Kim, S., Saeidi, S., Kim, S. H., Fang, X., Lee, Y., Quispe, Y. N. G., Ngo, H. K. C., Kim, D., Kim, D., et al. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.11.039 · Cited by 57
Hubert, A., Paris, S., Piret, J., Ninane, N., Raes, M. J., & Michiels, C. (2006) · Journal of Cell Science · doi:10.1242/jcs.03069 · Cited by 65
Du, J., Chen, Y., Li, Q., Han, X., Cheng, C., Wang, Z., Danielpour, D., Dunwoodie, S. L., Bunting, K. D., & Yang, Y. (2012) · Blood · doi:10.1182/blood-2011-10-387902 · Cited by 62
Reporter Ligand NMR Screening Method for 2-Oxoglutarate Oxygenase Inhibitors
Leung, I. K. H., Demetriades, M., Hardy, A., Lejeune, C., Smart, T. J., Szöllössi, A., Kawamura, A., Schofield, C. J., & Claridge, T. D. W. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301583m · Cited by 62
Epigenetic programming of hypoxic–ischemic encephalopathy in response to fetal hypoxia
Ma, Q., & Zhang, L. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.11.001 · Cited by 63
Sakamoto, T., & Seiki, M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.019216 · Cited by 62
Hussain, M. S., & Tripathi, V. (2018) · Military Medical Research · doi:10.1186/s40779-018-0158-5 · Cited by 62
Cenigaonandia‐Campillo, A., Serna‐Blasco, R., Gómez-Ocabo, L., Casado, S. S., Baños‐Herraiz, N., del Puerto‐Nevado, L., Cañas, J. A., Fernández‐Aceñero, M. J., García‐Foncillas, J., & Aguilera, Ó. (2021) · Theranostics · doi:10.7150/thno.51265 · Cited by 61
Berchner‐Pfannschmidt, U., Tug, S., Trinidad, B., Oehme, F., Yamac, H., Wotzlaw, C., Flamme, I., & Fandrey, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804390200 · Cited by 61
MicroRNA‐31 targets FIH‐1 to positively regulate corneal epithelial glycogen metabolism
Peng, H., Hamanaka, R. B., Katsnelson, J., Hao, L., Yang, W., Chandel, N. S., & Lavker, R. M. (2012) · The FASEB Journal · doi:10.1096/fj.11-198515 · Cited by 63
Hypoxia-inducible factor-1alpha in hepatic fibrosis: A promising therapeutic target
Zhan, L., Huang, C., Meng, X., Song, Y., Wu, X. Q., Yang, Y., & Li, J. (2014) · Biochimie · doi:10.1016/j.biochi.2014.10.013 · Cited by 61
The Hypoxia–Adenosine Link during Intestinal Inflammation
Bowser, J. L., Phan, L. H., & Eltzschig, H. K. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701414 · Cited by 62
JAK2 unmutated erythrocytosis: 2023 Update on diagnosis and management
Gangat, N., Szuber, N., & Tefferi, A. (2023) · American Journal of Hematology · doi:10.1002/ajh.26920 · Cited by 61
Therapeutic targeting of hypoxia and hypoxia-inducible factor 1 alpha in multiple myeloma
Borsi, E., Terragna, C., Brioli, A., Tacchetti, P., Martello, M., & Cavo, M. (2014) · Translational research · doi:10.1016/j.trsl.2014.12.001 · Cited by 61
Hypoxic pathobiology of breast cancer metastasis
Schito, L., & Rey, S. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.05.004 · Cited by 63
Okamoto, A., Sumi, C., Tanaka, H., Kusunoki, M., Iwai, T., Nishi, K., Matsuo, Y., Harada, H., Takenaga, K., Bono, H. U., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-03980-7 · Cited by 60
Self-citationMitochondria and Hypoxia: Metabolic Crosstalk in Cell-Fate Decisions
Bargiela, D., Burr, S. P., & Chinnery, P. F. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2018.02.002 · Cited by 60
The small members of the JMJD protein family: Enzymatic jewels or jinxes?
Oh, S., Shin, S., & Janknecht, R. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.04.002 · Cited by 60
Development of targeted angiogenic medicine
Loges, S., Roncal, C., & Carmeliet, P. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03203.x · Cited by 62
The emerging role of hypoxia-inducible factor-2 involved in chemo/radioresistance in solid tumors
Zhao, J., Du, F., Luo, Y., Shen, G., Zheng, F., & Xu, B. (2015) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2015.05.004 · Cited by 59
Dale, E. A., Satriotomo, I., & Mitchell, G. S. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.0239-11.2011 · Cited by 60
Hypoxia signaling during intestinal ischemia and inflammation
Grenz, A., Clambey, E. T., & Eltzschig, H. K. (2012) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e3283514bd0 · Cited by 60
Regulation of vitamin metabolism by p53 and p63 in development and cancer
Zhou, H., & van Bokhoven, H. (2010) · Cell Cycle · doi:10.4161/cc.9.14.12591 · Cited by 61
Wilkins, S. E., Hyvärinen, J., Chicher, J., Gorman, J. J., Peet, D. J., Bilton, R. L., & Koivunen, P. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.01.005 · Cited by 61
Calpain Mediates a von Hippel-Lindau Protein–independent Destruction of Hypoxia-inducible Factor-1α
Zhou, J., Köhl, R., Herr, B., Frank, R., & Brüne, B. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-08-0770 · Cited by 61
Choi, J.-W., Park, S. C., Kang, G. H., Liu, J. O., & Youn, H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0145 · Cited by 60
Hypoxic regulation of the noncoding genome and NEAT1
Choudhry, H., & Mole, D. R. (2015) · Briefings in Functional Genomics · doi:10.1093/bfgp/elv050 · Cited by 59
Anti-angiogenic Therapy for Retinal Disease
Paulus, Y. M., & Sodhi, A. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_78 · Cited by 60
Role of the Aryl Hydrocarbon Receptor in Sugen 5416–induced Experimental Pulmonary Hypertension
Dean, A., Gregorc, T., Docherty, C. K., Harvey, K. Y., Nilsen, M., Morrell, N. W., & MacLean, M. R. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0260oc · Cited by 59
Luo, W., & Wang, Y. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2684-9 · Cited by 59
Molecular docking studies of angiogenesis target protein HIF-1α and genistein in breast cancer
Mukund, V., Saddala, M. S., Farran, B., Mannavarapu, M., Alam, A., & Nagaraju, G. P. (2019) · Gene · doi:10.1016/j.gene.2019.03.062 · Cited by 59
Induction of Hypoxia-inducible Factor 1 Activity by Muscarinic Acetylcholine Receptor Signaling
Hirota, K., Fukuda, R., Takabuchi, S., Kizaka‐Kondoh, S., Adachi, T., Fukuda, K., & Semenza, G. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405164200 · Cited by 59
Self-citationRetractedActivation of HIF-prolyl Hydroxylases by R59949, an Inhibitor of the Diacylglycerol Kinase
Temes, E., Martín-Puig, S., Acosta‐Iborra, B., Castellanos, M. C., Feijoo‐Cuaresma, M., Olmos, G., Aragonés, J., & Landázuri, M. O. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414694200 · Cited by 59
Choi, S., Choi, K.-O., Park, Y.-K., Cho, H.-J., Yang, E. G., & Park, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603913200 · Cited by 61
Birle, D. C., & Hedley, D. W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2722 · Cited by 58
Ren, L., Zhang, W., Han, P., Zhang, J., Zhu, Y., Meng, X., Zhang, J., Hu, Y., Yi, Z., & Wang, R. (2019) · Virology · doi:10.1016/j.virol.2019.02.010 · Cited by 60
Oxygen Tension Regulates Mitochondrial DNA-encoded Complex I Gene Expression
Piruat, J. I., & López‐Barneo, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507044200 · Cited by 59
Chen, T., Yao, L.-Q., Shi, Q., Ren, Z., Ye, L., Xu, J., Zhou, P., & Zhong, Y. (2014) · Cancer Biology & Therapy · doi:10.4161/cbt.28017 · Cited by 58
The hypoxia-inducible factor (HIF) couples immunity with metabolism
Halligan, D. N., Murphy, S. J. E., & Taylor, C. T. (2016) · Seminars in Immunology · doi:10.1016/j.smim.2016.09.004 · Cited by 59
Seo, H., Lee, S.-Y., Lee, C. Y., Kim, R., Kim, P., Oh, S., Lee, H., Lee, M. Y., Kim, J., Kim, L. K., et al. (2017) · Journal of Vascular Research · doi:10.1159/000461596 · Cited by 58
Metadata
- Authors
- Mahon, P. C., Hirota, K., & Semenza, G. L.
- Affiliations
- Johns Hopkins University (US)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2001-10-15
- Volume
- 15
- Issue
- 20
- Pages
- 2675-2686
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- PMC
- PMC312814
- OpenAlex
- W2089692551
- Semantic Scholar
- 76cac1c7209112ecf9989f7cc81e563b7881292c
- Cited by
- 1,385
- References
- 47
- Citations by year
- 2026: 23 · 2025: 31 · 2024: 40 · 2023: 52 · 2022: 63 · 2021: 71 · 2020: 58 · 2019: 64 · 2018: 47 · 2017: 50 · 2016: 61 · 2015: 60 · 2014: 54 · 2013: 56 · 2012: 59
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Uehara Memorial Foundation
- National Institutes of Health (5r01dk039869-16)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK39869)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Kruppel-like factors research
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Keywords
- FIH-1, HIF-1α, VHL, HIF-1, transcriptional repression, histone deacetylase, corepressors, oxygen sensing, protein-protein interaction, ubiquitination, proteasomal degradation, oxygen homeostasis
- MeSH terms
- Amino Acid Sequence, Animals, Cells, Cultured, DNA-Binding Proteins, Fungal Proteins, Gene Expression Regulation, Glutathione Transferase, Histone Deacetylases, Humans, Mixed Function Oxygenases, Ligases, Luciferases, Molecular Sequence Data, Nuclear Proteins, Oxygen, Protein Conformation, Rabbits, Repressor Proteins, Reticulocytes, Saccharomyces cerevisiae, Transcription Factors, Transcription, Genetic, Signal Transduction, Transcriptional Activation, Cell Hypoxia, Polymerase Chain Reaction, Sequence Homology, Amino Acid, DNA Primers, Two-Hybrid System Techniques, Tumor Suppressor Proteins, Saccharomyces cerevisiae Proteins, Ubiquitin-Protein Ligases, Von Hippel-Lindau Tumor Suppressor Protein, Hypoxia-Inducible Factor 1, alpha Subunit, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
